| Drugs in clinical trials for Alzheimer's disease: the major trends SO Bachurin, EV Bovina, AA Ustyugov Medicinal research reviews 37 (5), 1186-1225, 2017 | 351 | 2017 |
| Fused in Sarcoma (FUS) Protein Lacking Nuclear Localization Signal (NLS) and Major RNA Binding Motifs Triggers Proteinopathy and Severe Motor Phenotype in Transgenic Mice*♦ TA Shelkovnikova, OM Peters, AV Deykin, N Connor-Robson, ... Journal of biological chemistry 288 (35), 25266-25274, 2013 | 143 | 2013 |
| Chronic administration of dimebon ameliorates pathology in Tau P301S transgenic mice OM Peters, N Connor-Robson, VB Sokolov, AY Aksinenko, MS Kukharsky, ... Journal of Alzheimer's disease 33 (4), 1041-1049, 2013 | 79 | 2013 |
| Alzheimer's disease–future therapy based on dendrimers G Aliev, GM Ashraf, VV Tarasov, VN Chubarev, J Leszek, K Gasiorowski, ... Current Neuropharmacology 17 (3), 288-294, 2019 | 59 | 2019 |
| Dimebon slows progression of proteinopathy in γ-synuclein transgenic mice SO Bachurin, TA Shelkovnikova, AA Ustyugov, O Peters, I Khritankova, ... Neurotoxicity research 22, 33-42, 2012 | 58 | 2012 |
| 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment GF Makhaeva, SV Lushchekina, NP Boltneva, OG Serebryakova, ... Bioorganic & medicinal chemistry 25 (21), 5981-5994, 2017 | 55 | 2017 |
| FUS (1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy SY Funikov, AP Rezvykh, PV Mazin, AV Morozov, AV Maltsev, ... Neurogenetics 19, 189-204, 2018 | 44 | 2018 |
| Novel sites of neuroprotective action of Dimebon (latrepirdine) A Ustyugov, E Shevtsova, S Bachurin Molecular neurobiology 52, 970-978, 2015 | 42 | 2015 |
| Chikungunya virus inhibition by synthetic coumarin–guanosine conjugates JR Hwu, WC Huang, SY Lin, KT Tan, YC Hu, FK Shieh, SO Bachurin, ... European Journal of Medicinal Chemistry 166, 136-143, 2019 | 35 | 2019 |
| Hindering of proteinopathy-induced neurodegeneration as a new mechanism of action for neuroprotectors and cognition enhancing compounds SO Bachurin, AA Ustyugov, O Peters, TA Shelkovnikova, VL Buchman, ... Doklady. Biochemistry and Biophysics 428 (1), 235, 2009 | 32 | 2009 |
| The Y-box binding protein 1 suppresses Alzheimer’s disease progression in two animal models NV Bobkova, DN Lyabin, NI Medvinskaya, AN Samokhin, PV Nekrasov, ... PLoS One 10 (9), e0138867, 2015 | 30 | 2015 |
| Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice N Ninkina, TV Tarasova, KD Chaprov, AY Roman, MS Kukharsky, ... Neurobiology of Aging 91, 76-87, 2020 | 29 | 2020 |
| Loss of midbrain dopamine neurons and altered apomorphine EEG effects in the 5xFAD mouse model of Alzheimer’s disease V Vorobyov, B Bakharev, N Medvinskaya, I Nesterova, A Samokhin, ... Journal of Alzheimer's Disease 70 (1), 241-256, 2019 | 29 | 2019 |
| A novel resource for studying function and dysfunction of α-synuclein: mouse lines for modulation of endogenous Snca gene expression N Ninkina, N Connor-Robson, AA Ustyugov, TV Tarasova, ... Scientific Reports 5 (1), 16615, 2015 | 29 | 2015 |
| Hsp27 is persistently expressed in zebrafish skeletal and cardiac muscle tissues but dispensable for their morphogenesis NR Tucker, A Ustyugov, AL Bryantsev, ME Konkel, EA Shelden Cell Stress and Chaperones 14 (5), 521-533, 2009 | 27 | 2009 |
| Early lethality and neuronal proteinopathy in mice expressing cytoplasm-targeted FUS that lacks the RNA recognition motif HK Robinson, AV Deykin, EV Bronovitsky, RK Ovchinnikov, AA Ustyugov, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16 (5-6), 402-409, 2015 | 26 | 2015 |
| Блокада нейродегенеративных процессов, вызванных протеинопатией, как новый механизм действия нейропротекторных и когнитивно-стимулирующих препаратов СО Бачурин, АА Устюгов, О Петерс, ТА Шелковникова, ВЛ Бухман, ... Доклады Академии наук 428 (2), 262-265, 2009 | 25 | 2009 |
| Novel positive allosteric modulators of AMPA receptors based on 3, 7-diazabicyclo [3.3. 1] nonane scaffold MI Lavrov, DS Karlov, TA Voronina, VV Grigoriev, AA Ustyugov, ... Molecular Neurobiology 57, 191-199, 2020 | 24 | 2020 |
| C9ORF72 hexanucleotide repeat expansion in ALS patients from the Central European Russia population NY Abramycheva, EV Lysogorskaia, MS Stepanova, MN Zakharova, ... Neurobiology of aging 36 (10), 2908. e5-2908. e9, 2015 | 23 | 2015 |
| A mice model of amyotrophic lateral sclerosis expressing mutant human FUS protein AV Deĭkin, EA Kovrazhkina, RK Ovchinnikov, EV Bronovitskiĭ, ... Zhurnal nevrologii i psikhiatrii imeni SS Korsakova 114 (8), 62-69, 2014 | 21* | 2014 |
Tatyana ShelkovnikovaSITraN, University of SheffieldVerified email at sheffield.ac.uk
